Zobrazeno 1 - 10
of 54
pro vyhledávání: '"Maarten J. IJzerman"'
Autor:
Janine A. van Til, Michelle M. A. Kip, Ellen J. H. Schatorjé, Gillian Currie, Marinka Twilt, Susanne M. Benseler, Joost F. Swart, Sebastiaan J. Vastert, Nico Wulffraat, Rae S. M. Yeung, C. G. M. (Karin) Groothuis-Oudshoorn, Sanne Warta, Deborah A. Marshall, Maarten J. IJzerman, on behalf of the UCAN CAN-DU, UCAN CURE consortia
Publikováno v:
Pediatric Rheumatology Online Journal, Vol 21, Iss 1, Pp 1-10 (2023)
Abstract Objective Approximately one third of children with JIA receive biologic therapy, but evidence on biologic therapy withdrawal is lacking. This study aims to increase our understanding of whether and when pediatric rheumatologists postpone a d
Externí odkaz:
https://doaj.org/article/e8886f2cb6b24106ac37e71fabf711fd
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Background: Although several strategies for modelling competing events in discrete event simulation (DES) exist, a methodological gap for the event-specific probabilities and distributions (ESPD) approach when dealing with censored data remains. This
Externí odkaz:
https://doaj.org/article/d06ebcc13dd747928671ed73ef70276d
Autor:
Deon Lingervelder, Michelle M. A. Kip, Eva D. Wiese, Hendrik Koffijberg, Maarten J. Ijzerman, Ron Kusters
Publikováno v:
BMC Health Services Research, Vol 22, Iss 1, Pp 1-11 (2022)
Abstract Background Diabetes mellitus, cardiovascular diseases, chronic kidney disease, and thyroid diseases are chronic diseases that require regular monitoring through blood tests. This paper first investigates the experiences of chronic care patie
Externí odkaz:
https://doaj.org/article/c20fa77e2f494ce682bcd32ed12e8776
Autor:
Joost J. Enzing, Saskia Knies, Jop Engel, Maarten J. IJzerman, Beate Sander, Rick Vreman, Bert Boer, Werner B. F. Brouwer
Publikováno v:
Cost Effectiveness and Resource Allocation, Vol 20, Iss 1, Pp 1-12 (2022)
Abstract Introduction Drug reimbursement decisions are often made based on a price set by the manufacturer. In some cases, this price leads to public and scientific debates about whether its level can be justified in relation to its costs, including
Externí odkaz:
https://doaj.org/article/7a43d19d39c6441bbadfd1fdfdf97ada
Autor:
Luiza R. Grazziotin, Gillian Currie, Marinka Twilt, Maarten J. IJzerman, Michelle M. A. Kip, Hendrik Koffijberg, Gouke Bonsel, Susanne M. Benseler, Joost F. Swart, Sebastiaan J. Vastert, Nico M. Wulffraat, Rae S. M. Yeung, Wineke Armbrust, J. Merlijn van den Berg, Deborah A. Marshall
Publikováno v:
Pediatric Rheumatology Online Journal, Vol 20, Iss 1, Pp 1-12 (2022)
Abstract Objective This study investigates the relationship of child, caregiver, and caring context measurements with the care-related quality of life (CRQoL) and health-related quality of life (HRQoL) of caregivers of children with juvenile idiopath
Externí odkaz:
https://doaj.org/article/41953f65f31d4feda4a954f764c7ab3b
Autor:
Luiza R. Grazziotin, Gillian Currie, Marinka Twilt, Maarten J. Ijzerman, Michelle M. A. Kip, Hendrik Koffijberg, Susanne M. Benseler, Joost F. Swart, Sebastiaan J. Vastert, Nico M. Wulffraat, Rae S. M. Yeung, Deborah A. Marshall
Publikováno v:
Pediatric Rheumatology Online Journal, Vol 20, Iss 1, Pp 1-11 (2022)
Abstract Objective Pharmacological treatment is a cornerstone of care for children with juvenile idiopathic arthritis (JIA). The objective of this study is to evaluate prescription patterns of conventional and biologic disease modifying anti-rheumati
Externí odkaz:
https://doaj.org/article/1351308fd51748cf8ddd7971b6fbf134
Autor:
Frederik A. van Delft, Milou Schuurbiers, Mirte Muller, Sjaak A. Burgers, Huub H. van Rossum, Maarten J. IJzerman, Hendrik Koffijberg, Michel M. van den Heuvel
Publikováno v:
Heliyon, Vol 8, Iss 10, Pp e10932- (2022)
Serum tumor markers acquired through a blood draw are known to reflect tumor activity. Their non-invasive nature allows for more frequent testing compared to traditional imaging methods used for response evaluations. Our study aims to compare nine pr
Externí odkaz:
https://doaj.org/article/457e2192e21a4b678c80294951df3697
Autor:
Koen Degeling, Amanda Pereira-Salgado, Niall M. Corcoran, Paul C. Boutros, Peter Kuhn, Maarten J. IJzerman
Publikováno v:
European Urology Open Science, Vol 27, Iss , Pp 77-87 (2021)
Context: Several liquid- and tissue-based biomarker tests (LTBTs) are available to inform the need for prostate biopsies and treatment of localised prostate cancer (PCa) through risk stratification, but translation into routine practice requires evid
Externí odkaz:
https://doaj.org/article/cd3b4c515cc74f9bb2e28d3f409bb4c7
Autor:
Michiel van de Ven, Martijn J. H. G. Simons, Hendrik Koffijberg, Manuela A. Joore, Maarten J. IJzerman, Valesca P. Retèl, Wim H. van Harten
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-12 (2021)
Abstract Background In oncology, Whole Genome Sequencing (WGS) is not yet widely implemented due to uncertainties such as the required infrastructure and expertise, costs and reimbursements, and unknown pan-cancer clinical utility. Therefore, this st
Externí odkaz:
https://doaj.org/article/d922fbd1e74a4e068c3f975538235bae
Autor:
Robert K. Mahar, Myra B. McGuinness, Bibhas Chakraborty, John B. Carlin, Maarten J. IJzerman, Julie A. Simpson
Publikováno v:
BMC Medical Research Methodology, Vol 21, Iss 1, Pp 1-13 (2021)
Abstract Background Dynamic treatment regimens (DTRs) formalise the multi-stage and dynamic decision problems that clinicians often face when treating chronic or progressive medical conditions. Compared to randomised controlled trials, using observat
Externí odkaz:
https://doaj.org/article/9376f4f92a814e18a6d83e56fee59c18